History, presence, and future of mitomycin C in glaucoma filtration surgery

Wolters J.E.J., van Mechelen R.J.S., Al Majidi R., Pinchuk L., Webers C.A.B., Beckers H.J.M., Gorgels T.G.M.F.

2021
Current opinion in ophthalmology

Therapeutic Area

Glaucoma
Categories

Post-Approval studies/RWE

Affiliations

Wolters, J.E.J., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; van Mechelen, R.J.S., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; Al Majidi, R., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; Pinchuk, L., InnFocus, Inc., Santen Company, Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, United States; Webers, C.A.B., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands; Beckers, H.J.M., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands; Gorgels, T.G.M.F., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands

Related Publications

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study

Akagi T.; Fukuchi T.; Higashide T.; Udagawa S.; Ohkubo S.; Sugiyama K.; Tanihara H.; Araie M.; Tomita G.; Matsumoto C.; Tomidokoro A.; Hangai M.; Kawata H.; Inai M.; Tanaka Y.; SVF Prospector Study Group

Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study

Takada N.; Ishikawa M.; Sato K.; Kunikata H.; Ninomiya T.; Hanyuda A.; Fukuda E.; Yamaguchi K.; Ono C.; Kirihara T.; Shintani C.; Tsusu C.; Osanai A.; Goshima N.; Izumi Y.; Zorumski C.F.; Nakazawa T.

Bioequivalence of Preservative-free and Preserved Omidenepag Isopropyl (OMDI) 0.002% Ophthalmic Solutions in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Results from the Phase 3 DAISY Study

Aihara M.; Lu F.; Ikeda T.; Odani-Kawabata N.